Sugi Predict

Sugi Predict / Compounds / Acetamide

Acetamide

Acetamide

SCHEMBL1694656

CC(N)=O.CCN1CCCC1=O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.61
▸ LMNA P02545 3/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ CA3 P07451 1/20 0.50
▸ CA4 P22748 1/20 0.50
▸ CA6 P23280 1/20 0.50
▸ CA5A P35218 1/20 0.50
▸ CA7 P43166 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ CA13 Q8N1Q1 1/20 0.50
▸ CA14 Q9ULX7 1/20 0.50
▸ CA5B Q9Y2D0 1/20 0.50
▸ INMT O95050 1/20 0.49
▸ PIK3CD O00329 1/20 0.48
▸ KMT2A Q03164 2/20 0.46
▸ HTT P42858 1/20 0.41
▸ CHRM2 P08172 2/20 0.41
▸ CHRM5 P08912 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetone SCHEMBL25437214 0.92 TSHR (0.55) TSHRLMNACA12CA1CA2
Acetic Acid SCHEMBL5493148 0.90 INMT (0.55) TSHRLMNACA12CA1CA2
SCHEMBL27958225 0.88 PIK3CD (0.59) TSHRLMNAINMTPIK3CDKMT2A
SCHEMBL18635 0.88 — —
Alcohol SCHEMBL5284370 0.86 PIK3CD (0.53) TSHRLMNACA12CA1CA2
Water SCHEMBL6122410 0.86 — —
Arsenic SCHEMBL28843817 0.86 — —
Hydrochloric Acid SCHEMBL23248746 0.86 — —
Water SCHEMBL6122968 0.86 PIK3CD (0.57) TSHRLMNAINMTPIK3CDKMT2A
SCHEMBL30679684 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104666263-B A kind of tablet containing Levetiracetam and preparation method thereof 海南华益泰康药业有限公司 2017-07-11 — — CN disclosed
EP-2968994-A1 RAPID DISPERSE DOSAGE FORM CONTAINING LEVETIRACETAM Aprecia Pharmaceuticals Company (US) 2016-01-20 — — EP disclosed
WO-2014144512-A1 RAPID DISPERSE DOSAGE FORM CONTAINING LEVETIRACETAM APRECIA PHARMACEUTICALS COMPANY (US) 2014-09-18 — — WO disclosed
WO-2012070785-A1 SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION COMPRISING LEVETIRACETAM OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF HAVING IMPROVED DISSOLUTION STABILITY AND METHOD FOR MANUFACTURING THE SAME BIO PHARMARTIS CO., LTD. (KR) 2012-05-31 — — WO disclosed
WO-2011159491-A2 CONTROLLED RELEASE LEVETIRACETAM FORMULATIONS MYLAN, INC. (US) 2011-12-22 — — WO disclosed
EP-1879861-A2 PROCESS FOR PREPARING LEVETIRACETAM AND RACEMIZATION OF (R)- AND (S)-2-AMINO BUTYNAMIDE AND THE CORRESPONDING ACID DERIVATIVES Rubamin Laboratories Limited (IN) 2008-01-23 — — EP disclosed
EP-1863761-A1 PROCESS FOR PREPARING LEVETIRACETAM Rubamin Limited (IN) 2007-12-12 — — EP disclosed
CN-101027047-A Methods for identifying agents for treating seizures, neurological, endocrinological and hormonal disorders UCB INC (BE) 2007-08-29 — — CN disclosed
WO-2006103696-A2 PROCESS FOR PREPARING LEVETIRACETAM AND RACEMIZATION OF (R)- AND (S)-2-AMINO BUTYNAMIDE AND THE CORRESPONDING ACID DERIVATIVES RUBAMIN LABORATORIES LIMITED (IN) 2006-10-05 — — WO disclosed
EP-1706376-A1 IMIDAZOLE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB, S.A. (BE) 2006-10-04 — — EP disclosed
WO-2006095362-A1 PROCESS FOR PREPARING LEVETIRACETAM RUBAMIN LIMITED (IN) 2006-09-14 — — WO disclosed
WO-2005054188-A1 IMIDAZOLE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB, S.A. (BE) 2005-06-16 — — WO disclosed
EP-1263727-A1 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR USES UCB Farchim S.A. (AG - LTD) (CH) 2002-12-11 — — EP disclosed
WO-2001064637-A1 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR USES UCB FARCHIM S.A. (AG - LTD) (CH) 2001-09-07 — — WO disclosed